ImmunoGen, Inc.

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. Show More...

Website http://www.immunogen.com
Sector Healthcare
Industry Biotechnology
Last Quote 31.23 USD
Last Updated 09-02-2024
External Links Yahoo Finance Morningstar Ratios
Interest Coverage

The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia

	2010-06	2011-06	2012-06	2013-06	2014-06	2015-06	2016-06	2017-12	2018-12	2019-12	TTM
Earnings Per Share USD	-0.87	-0.85	-0.95	-0.87	-0.83	-0.71	-1.67	-0.98	-1.21	-0.7	-0.57
Dividends USD
Payout Ratio % *
Shares Mil	59.0	69.0	77.0	84.0	85.0	86.0	87.0	98.0	140.0	148.0	153.0
Book Value Per Share * USD								-0.84	0.31	-0.57	-0.02
Free Cash Flow Per Share * USD								-1.13	-1.18	-0.68
Return on Assets %	-42.8	-32.84	-36.85	-36.97	-37.67	-25.35	-48.2	-38.91	-57.23	-39.25	-28.73
Financial Leverage (Average)	1.34	1.55	2.15	1.75	2.18	8.94			26.92
Return on Equity %	-60.28	-48.16	-65.5	-70.78	-72.25	-109.63
Return on Invested Capital %	-60.28	-48.16	-65.5	-70.78	-72.25	-99.82
Interest Coverage						-10.17	-6.19	-4.74	-14.74	-5.13	-3.65
Current Ratio	8.47	13.84	10.23	10.47	7.09	8.16	4.15	4.96	3.95	2.7	3.17
Quick Ratio	8.23	13.45	9.98	10.28	6.85	7.93	4.03	4.88	3.88	2.63	3.08
Debt/Equity									0.19

ImmunoGen, Inc.

Interest Coverage